Finance

Lists
DD:NYSE
DuPont de Nemours Inc
USD 129,98
+0,60%
(+0,78) 1D
2 Okt., 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DD...
Open
USD 130,74
High
USD 130,86
Low
USD 129,14
Mkt. cap
17,55 mjd
Avg. vol.
1,13 m
Volume
0,00
Dividend
1,85%
Quarterly dividend
USD 0,60
Ex-dividend date
31 Aug. 2026
P/E ratio
308,92
52-wk high
USD 157,98
52-wk low
USD 92,45
EPS
USD 0,42
Beta
1,04
Shares outstanding
135,04 m
No. of employees
15 k
Open
USD 130,74
High
USD 130,86
Low
USD 129,14
Mkt. cap
17,55 mjd
Avg. vol.
1,13 m
Volume
0,00
Dividend
1,85%
Quarterly dividend
USD 0,60
Ex-dividend date
31 Aug. 2026
P/E ratio
308,92
52-wk high
USD 157,98
52-wk low
USD 92,45
EPS
USD 0,42
Beta
1,04
Shares outstanding
135,04 m
No. of employees
15 k
News stories
From web sources and news partners
Profile
DuPont de Nemours, Inc., commonly shortened to DuPont, is a company headquartered and organized in Delaware that produces products for the healthcare, water, construction and industrial markets. It was formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company operates two divisions: Healthcare & Water Technologies, which produces medical packaging such as Tyvek packaging and Tychem protective suits as well as Amberlite ion exchange resins, Filmtec reverse osmosis and nanofiltration elements and Inge and Itegratec ultrafiltration modules; and Diversified Industrials, which produces products for repair‑and‑remodel construction such as Tyvek house wrap, Styrofoam insulation, Corian, Vespel shapes and parts, Molykote lubricants, Betaforce, and Betaseal. The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder. Wikipedia
About DuPont de Nemours Inc
CEOLori Koch
Employees15 k
Founded31 Aug. 2017
Headquarters-
SectorConglomerate
Websitedupont.com
Analyst ratings
Based on 7 analysts giving stock ratings to DD in the past 3 months
Buy
Buy
5
Hold
2
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for DD in the last 3 months.
Highest
Current USD 129,98
USD 186,00 (+43,10%)
Average
USD 169,57 (+30,46%)
Lowest
USD 156,00 (+20,02%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joshua Spector
UBS
Buy
Maintained
USD 172,00
+32,3%
10/05/2026
Abigail Eberts
Wells Fargo
Buy
Reiterated
USD 166,00
+27,7%
09/17/2026
Chigusa Katoku
J.P. Morgan
Buy
Reiterated
USD 172,00
+32,3%
08/10/2026
John McNulty
BMO Capital
Buy
Maintained
USD 186,00
+43,1%
08/09/2026
Arun Viswanathan
RBC Capital
Buy
Maintained
USD 176,00
+35,4%
08/06/2026
Vincent Andrews
Morgan Stanley
Hold
Maintained
USD 156,00
+20%
08/06/2026
Matthew DeYoe
Bank of America Securities
Hold
Maintained
USD 159,00
+22,3%
08/05/2026
John Roberts CFA
Mizuho Securities
Buy
Maintained
USD 156,00
+20%
07/02/2026
Patrick Cunningham
Citi
Buy
Reiterated
USD 170,00
+30,8%
07/01/2026
Joe Ritchie
Goldman Sachs
Hold
Initiated
USD 159,00
+22,3%
06/15/2026
Michael Sison
Wells Fargo
Buy
Reiterated
USD 165,00
+26,9%
05/26/2026
David Begleiter
Deutsche Bank
Buy
Maintained
USD 180,00
+38,5%
05/07/2026
Laurence Alexander
Jefferies
Buy
Maintained
USD 59,00
-54,6%
02/11/2026
Last report
04 Aug. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
USD 1,88 / USD 1,76
+6,75%beat
Revenue / Est. (USD)
1,82 mjd / 1,81 mjd
+0,37%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,07 mjd
-1,87 mjd
1,68 mjd
1,82 mjd
Cost of goods sold
1,88 mjd
-816,00 m
1,08 mjd
1,18 mjd
Cost of revenue
1,88 mjd
-816,00 m
1,08 mjd
1,18 mjd
Research and development expenses
140,00 m
-211,00 m
47,00 m
42,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
388,00 m
-111,00 m
255,00 m
270,00 m
Operating expense
649,00 m
-406,00 m
370,00 m
380,00 m
Total operating expenses
2,53 mjd
-1,22 mjd
1,45 mjd
1,56 mjd
Operating income
546,00 m
-649,00 m
232,00 m
259,00 m
Other non operating income
5,00 m
-46,00 m
10,00 m
4,00 m
EBT including unusual items
327,00 m
-738,00 m
181,00 m
266,00 m
EBT excluding unusual items
482,00 m
-719,00 m
221,00 m
262,00 m
Income tax expense
19,00 m
-89,00 m
31,00 m
75,00 m
Effective tax rate
5,81%
12,06%
17,13%
28,20%
Other operating expenses
-
-
-
-
Net income
-123,00 m
-126,00 m
161,00 m
143,00 m
Net profit margin
-4,00%
6,73%
9,58%
7,86%
Earnings per share
3,27
1,38
1,65
1,88
Interest and investment income
27,00 m
30,00 m
10,00 m
27,00 m
Interest expense
-99,00 m
-16,00 m
-40,00 m
-41,00 m
Net interest expenses
-72,00 m
14,00 m
-30,00 m
-14,00 m
Depreciation and amortization charges
-
-84,00 m
-
-
EBITDA
729,00 m
-487,25 m
387,00 m
413,00 m
Gain or loss from assets sale
-
-3,00 m
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme